Development of a concentration‐controlled sequential nanoprecipitation for making lipid nanoparticles with high drug loading
Open Access
Abstract
Lipid‐based nanostructures have garnered considerable interests over the last two decades, and have achieved tremendous clinical success including the first clinical approval of a liposome (Doxil) for cancer therapy in 1995 and the recent COVID‐19 mRNA lipid nanoparticle vaccines. Compared to liposomes which have a lipid bilayer surrounding an aqueous core, lipid nanoparticles with a particle structure have several attractive advantages for encapsulating poorly water‐soluble drugs such as better stability due to the particle structure, high drug encapsulation efficiency because of a pre‐ or co‐drug‐loading strategy. While many studies have reported the synthesis of lipid nanoparticles for hydrophobic drug encapsulation, the precise control of drug loading and encapsulation efficiency remains a significant challenge. This work reports a new concentration‐controlled nanoprecipitation platform technology for fabricating lipid nanoparticles with tunable drug loading up to 70 wt%. This method is applicable for encapsulating a wide range of drugs from very hydrophobic to slightly hydrophilic. Using this facile method, nanoparticles with tunable drug loading exhibited excellent properties such as small particle size, narrow size distribution, good particle stability, showing great promise for future drug delivery applications.Keywords
This publication has 27 references indexed in Scilit:
- Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticlesResearch in Pharmaceutical Sciences, 2017
- Microfluidic synthesis of multifunctional liposomes for tumour targetingColloids and Surfaces B: Biointerfaces, 2016
- Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to ComePharmacological Reviews, 2016
- Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacyBiomaterials, 2013
- Protein PEGylation Attenuates Adsorption and Aggregation on a Negatively Charged and Moderately Hydrophobic Polymer SurfaceLangmuir, 2010
- Liposome Formulations of Hydrophobic Drugs2009
- Synthetic polymeric nanoparticles by nanoprecipitationJournal of Materials Chemistry, 2009
- Topoisomerase I inhibitors: camptothecins and beyondNature Reviews Cancer, 2006
- Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion techniqueInternational Journal of Pharmaceutics, 2003
- Nanocapsule formation by interfacial polymer deposition following solvent displacementInternational Journal of Pharmaceutics, 1989